Could GLP-1 medications such as semaglutide do more than support weight loss? Emerging research suggests they may also have a direct effect on how lymphatic vessels function.
Dr. Jorge Castorena, recipient of Tulane University’s 2025 Rising Star Award, joined Dr. Karen Herbst to discuss his groundbreaking research, published in Microcirculation, and what it could mean for the future of lymphedema treatment and prevention.
Key Takeaways
- A promising discovery: Laboratory studies demonstrated that semaglutide improved the pumping capacity of lymphatic vessels, helping them move more fluid and overcome greater pressure.
- Understanding the mechanism: Researchers identified GLP-1 receptors on lymphatic endothelial cells. Activating these receptors stimulates nitric oxide release, allowing vessels to dilate while maintaining effective contractions.
- Beyond weight loss: These findings suggest GLP-1 medications may improve lymphatic function directly, rather than solely through weight reduction or reduced inflammation.
- Important unanswered questions: Could similar benefits occur with tirzepatide or other GLP-1 medications? Could lower doses improve lymphatic function without significant weight loss? Might these medications eventually help prevent secondary lymphedema following cancer treatment?
- What’s next: With NIH support, Dr. Castorena’s team is expanding its research to human lymphatic tissues, including samples from bariatric surgery patients.
What Does This Mean for Patients and Clinicians?
While early findings are encouraging, more research, particularly human clinical trials, is needed to determine whether GLP-1 medications can safely and effectively treat or prevent lymphedema. Their potential applications for lipedema also warrant further investigation.
Important Medical Disclaimer: This Research Roundtable is provided for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. The research discussed is preliminary and should not be interpreted as proof of clinical effectiveness. Patients should consult their qualified healthcare providers before starting, stopping, or changing any medication or treatment.
Learn more: www.lymphapress.com
